RA Capital Management Slashes Alcobra Ltd (ADHD) Position After FDA Clinical Hold

Page 2 of 8 – SEC Filing
CUSIP No. M2239P109 13G
1.

Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).

RA Capital Management, LLC

2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)  ¨
(b)  ¨
3. SEC Use Only
4. Citizenship or Place of Organization         Massachusetts
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power                           0 shares
6. Shared Voting Power            1,308,234 shares
7. Sole Dispositive Power                 0 shares
8. Shared Dispositive Power      1,308,234 shares
9.

Aggregate Amount Beneficially Owned by Each Reporting Person

1,308,234 shares

10.

Check if the Aggregate Amount
in Row (9) Excludes
¨

Certain Shares (See Instructions)

11.

Percent of Class Represented by Amount in Row (9)

4.7%1

12.

Type of Reporting Person (See Instructions)

IA

 

___________________________________

1 The reporting person is the beneficial owner of
1,308,234 ordinary shares of the Issuer which constitute approximately 4.7% of the Issuer’s outstanding ordinary shares.
The percentage calculation assumes that there are currently 27,560,920 outstanding ordinary shares of the Issuer, based on the
Issuer’s Form 20-F as filed with the Securities and Exchange Commission (“SEC”) on March 4, 2016.

 

Follow Arcturus Therapeutics Ltd. (NASDAQ:ARCT)